Skip to the list

France

The 16 companies from this country listed on the NYSE and Nasdaq are worth $350 bn combined; the largest are TotalEnergies (TTE), Sanofi (SNY) and STMicroelectronics (STM). For each one: the industry, what it does, revenue, margin, free cash flow over the last five years and a score from 0 to 10.

Data as of October 2026

16 companies 13 industries value 350 bn revenue 291 bn
Rank Ticker Company Value Revenue Margin FCF 5 years FCF/px Yield What it does · why it is here
1 TTE TotalEnergies
Integrated oil · score 7.9
199 bn 215 bn 8.4% 33 bn 16.6% 4.5% Oil, gas, LNG and low-carbon electricity · Biggest investor in renewables among the integrated oil majors
2 SNY Sanofi 97 bn 51 bn 8.7% 13 bn 13.8% — Medicines and vaccines, with Dupixent, from France · Dupixent, one of the world's fastest-growing drugs; strong in vaccines
3 STM STMicroelectronics 41 bn 12 bn 1.4% 2.1 bn 5.3% 0.8% Semiconductors for automotive and industrial, from Switzerland · Major European supplier to the automotive and industrial markets
4 ABVX Abivax S.A. 6.9 bn 0.0 bn -80x -0.2 bn -3.2% — Therapies for chronic inflammatory diseases, from France · France — revenue of $6m
5 CSTM Constellium
Aluminum · score 5.6
3.5 bn 9.6 bn 5.7% 0.2 bn 6.3% — Rolled and extruded aluminum products, from France · Rolled aluminum products for cans, automotive and aerospace
6 NBTX Nanobiotix S.A. 1.0 bn 0.0 bn -42.6% -0.0 bn -3.9% — Nanoparticle-enhanced radiotherapy, from France · France — revenue of $13m
7 CRTO Criteo 0.7 bn 1.9 bn 5.6% 0.2 bn 23.8% — Personalized advertising and shopping retargeting · Retargeting advertising and retail media
8 IVA Inventiva S.A. 0.7 bn 0.0 bn -5051x -0.1 bn -15.4% — Medicines for liver diseases, from France · France
9 VALN Valneva SE
Vaccines and mRNA · score 0.0
0.5 bn 0.2 bn -110.3% -0.1 bn -13.6% — Vaccines for infectious diseases, from France · France — revenue of $160m
10 HKD AMTD Digital Inc. 0.5 bn 0.1 bn 71.3% 0.0 bn 2.7% — Digital and media services, from Hong Kong · France — revenue of $136m
11 DBVT DBV Technologies S.A. 0.5 bn 0.0 bn -35x -0.2 bn -32.1% — Late-stage immunotherapy biopharma with the Viaskin platform · France — revenue of $5m
12 IPHA Innate Pharma SA 0.2 bn 0.0 bn -483.8% -0.1 bn -29.4% — NK cell antibody oncology, from France · France — revenue of $11m
13 CLLS Cellectis S.A.
Biotechnology · score 0.0
0.1 bn 0.1 bn -115.4% -0.0 bn -47.2% — Allogeneic CAR-T cell immunotherapy, from France · France — revenue of $57m
14 AMTD AMTD IDEA GROUP 0.0 bn 0.1 bn 66.4% 0.0 bn 21x — Financial and digital media services, from Hong Kong · France — assets of $2.3bn
15 SQNS SEQUANS COMMUNICATIONS
RF and mobile chips · score 0.0
0.0 bn 0.0 bn -415.1% -0.0 bn -73.2% — Cellular connectivity chips for the Internet of Things, from France · France — revenue of $26m
16 FOCL EDAP TMS SA — 0.1 bn -49.1% -0.0 bn — — Ultrasound equipment for prostate cancer treatment, from France · France — revenue of $79m

By sector

Sector Companies Value Revenue Largest
Health Care 9 106 bn 52 bn SNY, ABVX, NBTX
Information Technology 2 41 bn 12 bn STM, SQNS
Communication Services 2 1.2 bn 2.0 bn CRTO, HKD
Energy 1 199 bn 215 bn TTE
Materials 1 3.5 bn 9.6 bn CSTM
Financials 1 — 0.1 bn AMTD

Companies by country

What this is. A catalogue, not a guide. Every industry with stocks listed on the NYSE or NASDAQ, the companies contending for its leadership, what each one does according to its own annual report, and the balance sheet it filed with the SEC.

The score runs from 0 to 10 and compares each company with every other one in the almanac on cash generation, profitability, debt, dividends and consistency over the last five years. The higher it is, the better the company fares in that comparison. Curious how much each part weighs? Ask at the bottom of the page.

Have a question or a suggestion, or found a mistake?

Write here: a question about the score, a missing company or industry, a number that looks wrong. Every message is read, and the email is so I can reply.